14 tracked fund houses held AMBUJACEM in Aug 2026. None entered or exited.
All tracked schemes together held 17.63 cr shares, 7.09% of equity, worth ₹7,070 cr at the end of Aug 2026.
Index and arbitrage funds held 1.51% of equity; they are left out of the fund-house counts.
Top buyer Aditya Birla Sun Life Mutual Fund, +0.16% of equity. Top seller ICICI Prudential Mutual Fund, −0.21% of equity. Index and arbitrage funds hidden.
FPI category I + II, % of total shares · 0 named at 1% or more
No FPI held 1% or more of AMBUJACEM on 30 Jun 2026.
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 167.21 cr shares on 30 Jun 2026.
percentile 83 of 30 days collected
900 shares, under 0.01% of equity in SLBS open positions at the end of 25 Sep 2026; that day sits at percentile 83 of 30 days collected. No SLBM trades in AMBUJACEM on 25 Sep 2026.
percentile 83 of 29 days collected · ₹270 cr financed
60.73 lakh shares, 0.24% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 83 of 29 days collected.
20-day average 47.4% · percentile 47 of 30 days collected
45.9% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 47.4%; that day sits at percentile 47 of 30 days collected.
MWPL used 81.9% on 25 Sep 2026 · ban above 95%, lifted below 80%
AMBUJACEM was not in the F&O ban period on 25 Sep 2026; 81.9% of its market-wide position limit was used on 25 Sep 2026. In the ban on 0 of 30 days collected. NSE listed AMBUJACEM under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.